{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Ulcer", "query": { "condition": "Oral Ulcer" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 90, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Ulcer&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T15:10:44.085Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01759056", "title": "Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "AVX 470", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avaxia Biologics, Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 33, "start_date": "2013-02", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-03-05", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 9, "location_summary": "Anaheim, California • Lakewood, Colorado • Winter Park, Florida + 6 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Chevy Chase", "state": "Maryland" }, { "city": "Chesterfield", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01759056" }, { "nct_id": "NCT00573924", "title": "Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peptic Ulcer Hemorrhage" ], "interventions": [ { "name": "Proton pump inhibitor (lansoprazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2006-02", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2011-02-08", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573924" }, { "nct_id": "NCT00230191", "title": "Safety and Efficacy of RK0202 in Oral Mucositis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mouth Diseases", "Mouth Ulcers", "Oral Mucositis", "Head and Neck Cancer" ], "interventions": [ { "name": "RK-0202", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "RxKinetix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2003-01", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2007-01-15", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 6, "location_summary": "Los Angeles, California • Tampa, Florida • Louisville, Kentucky + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Farmington", "state": "Massachusetts" }, { "city": "Toledo", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00230191" }, { "nct_id": "NCT03239834", "title": "Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Palatal Neoplasms", "Lip Neoplasm", "Gingival Neoplasms", "Leukoplakia, Oral", "Tongue Neoplasms", "Oropharyngeal Neoplasms", "Oral Ulcer" ], "interventions": [ { "name": "OncAlert", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Vigilant Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "23 Years", "maximum_age": null, "sex": "ALL", "summary": "23 Years and older" }, "enrollment_count": 893, "start_date": "2017-09-07", "completion_date": "2020-12-20", "has_results": false, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 26, "location_summary": "Beverly Hills, California • La Mesa, California • Loma Linda, California + 22 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Roseville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03239834" }, { "nct_id": "NCT01458574", "title": "A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "CP690,550", "type": "DRUG" }, { "name": "CP-690,550", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 593, "start_date": "2012-07-20", "completion_date": "2016-05-27", "has_results": true, "last_update_posted_date": "2017-05-18", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 94, "location_summary": "Mobile, Alabama • La Jolla, California • Oceanside, California + 47 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01458574" }, { "nct_id": "NCT00628433", "title": "Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "HE3286", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harbor Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 27, "start_date": "2008-02", "completion_date": "2009-05", "has_results": false, "last_update_posted_date": "2011-06-14", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 10, "location_summary": "Tucson, Arizona • Anaheim, California • Fresno, California + 6 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00628433" }, { "nct_id": "NCT02229136", "title": "Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stomatitis", "Oral Mucositis", "Neoplasm of the Breast", "Malignant Tumor of Breast" ], "interventions": [ { "name": "Miracle Mouthwash Plus Hydrocortisone", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "US Oncology Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 104, "start_date": "2014-09-04", "completion_date": "2022-11", "has_results": false, "last_update_posted_date": "2022-12-01", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 1, "location_summary": "US, Texas", "locations": [ { "city": "US", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02229136" }, { "nct_id": "NCT01465763", "title": "A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "tofacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 614, "start_date": "2012-04", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2016-06-07", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 71, "location_summary": "Mobile, Alabama • La Jolla, California • Los Angeles, California + 29 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01465763" }, { "nct_id": "NCT00775463", "title": "Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Sclerosis", "Scleroderma" ], "interventions": [ { "name": "treprostinil diethanolamine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "United Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 148, "start_date": "2009-05", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2023-12-28", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00775463" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-07-22T15:10:44.085Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" } ] }